Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jay Olson initiated coverage on BIOAGE Labs Inc (NASDAQ:BIOA) with an Outperform rating and announced a price target of $60. Bioage Labs shares closed at $21.56 on Tuesday. See how other analysts view this stock.
- B. Riley Securities analyst Drew Crum initiated coverage on Angel Studios Inc (NYSE:ANGX) with a Buy rating and announced a price target of $7. Angel Studios ...

5 days ago


